2002
DOI: 10.1016/s0008-6363(02)00276-6
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of nuclear factor- B activation by IRFI 042, protects against endotoxin-induced shock

Abstract: These data suggest that IRFI 042 blocks the activation of NF-kappaB, reduces TNF-alpha mRNA levels, and finally reverses endotoxic shock.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

5
34
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(39 citation statements)
references
References 19 publications
5
34
0
Order By: Relevance
“…As such, NFκB inhibition has been proposed as a potential therapy for patients with septic shock (Rahman and Fazal, 2011;Wheeler et al, 2009). However, pre-clinical studies provide conflicting evidence on whether NFκB inhibition attenuates or exacerbates endotoxemic shock (Altavilla et al, 2002;Courtine et al, 2011;Everhart et al, 2006;Fujihara et al, 2000;Gadjeva et al, 2004;Greten et al, 2007;Kisseleva et al, 2006;Lawrence et al, 2005;Liu et al, 1997;Matsuda et al, 2004;Sha et al, 1995;Sheehan et al, 2002;Ulloa et al, 2002). It is not surprising that completely inhibiting NFκB activity would have both beneficial and detrimental consequences.…”
Section: Introductionmentioning
confidence: 99%
“…As such, NFκB inhibition has been proposed as a potential therapy for patients with septic shock (Rahman and Fazal, 2011;Wheeler et al, 2009). However, pre-clinical studies provide conflicting evidence on whether NFκB inhibition attenuates or exacerbates endotoxemic shock (Altavilla et al, 2002;Courtine et al, 2011;Everhart et al, 2006;Fujihara et al, 2000;Gadjeva et al, 2004;Greten et al, 2007;Kisseleva et al, 2006;Lawrence et al, 2005;Liu et al, 1997;Matsuda et al, 2004;Sha et al, 1995;Sheehan et al, 2002;Ulloa et al, 2002). It is not surprising that completely inhibiting NFκB activity would have both beneficial and detrimental consequences.…”
Section: Introductionmentioning
confidence: 99%
“…When each of these solvent extracts (100 mg/kg) was pretreated with the LPS/D-GalN-induced lethality model, the groups of mice pretreated with the ethyl acetate and water extracts showed higher survival rates, 80% each, than others with the control value of 20% (Table 1). The ethyl acetate extract was further chromatographed on a silica gel column, a preparative TLC and a reverse-phase gel column to afford twelve lignan compounds (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12). Their structures were characterized as sarisan (1), erythro-austrobailignan-6 (2), meso-dihydroguaiaretic acid (3), saucerneol B (4), manassantin B (5), manassantin A (6), rel-(8R,8ЈR)-dimethyl-(7S,7ЈR)-bis(3,4-methylenedioxyphenyl)tetrahydro-furan (7), (ϩ)-saururinone (8), sauchinone (9), sauchinone B (10), nectandrin B (11), and machilin D (12).…”
Section: Resultsmentioning
confidence: 99%
“…6) Loss of hepatic function is one of the hallmarks of the development of multiple-organ failure associated with severe sepsis. 7,8) There have been reports that the synthetic compounds IRFI 042, 9) tyrphostin AG 126, 10) and SR 27388 11) show significant protection against lethality due to septic shock, and lysophosphatidylcholine (LPC) can effectively prevent and treat sepsis and microbial infections. 12) Recently, protective compounds against sepsis have been reported from medicinal plants.…”
mentioning
confidence: 99%
“…3) Loss of hepatic function is one of the hallmarks of the development of multiple-organ failure associated with severe sepsis. 4,5) There have been reports that the synthetic compounds IRFI 042, 6) tyrphostin AG 126, 7) and SR 27388 8) show significant protection against lethality due to septic shock, and lysophosphatidylcholine (LPC) can effectively prevent and treat sepsis and microbial infections. 9) Recently, protective compounds against sepsis have been reported from medicinal plants.…”
mentioning
confidence: 99%